Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_751562df05f1831baef905641425c407 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-00 |
filingDate |
2015-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d09251c6a1d822de25b0633e394e9a49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ce0099db1cbd1f971853c9e0811d39c |
publicationDate |
2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015192052-A1 |
titleOfInvention |
Egfr targeting compounds and methods of use thereof |
abstract |
Disclosed herein are compounds having activity as EGFR inhibitors. In some examples, the compounds can comprise an EGFR binding moiety; a linker; and a detectable moiety, therapeutic moiety, or a combination thereof. Also provided herein are methods of treating, preventing, detecting or ameliorating cancer in a subject. The disclosed subject matter also concerns methods for treating a subject having an inflammatory disorder or condition. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017175144-A1 |
priorityDate |
2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |